Immutep Limited's Customers Performance

Name: Immutep Limited Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

IMMP

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


IMMP's Source of Revenues		During the corresponding time, Immutep Limited recorded a revenue increase by 31.8 % year on year, While revenue at the Immutep Limited's corporate clients • List of IMMP Customers

for the same period Immutep Limited recorded revenue increase by 31.8 % year on year,

• List of IMMP Customers

Immutep Limited's Business Units


Immunotherapy	48.73 %	of total Revenue
Unallocated	51.27 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Immutep Limited's Comment on Sales, Marketing and Customers

News about Immutep Limited Contracts

Immutep Limiteds Promising Safety Data from IMP761 Phase I Trial A Glimmer of Hope Amidst Market Struggles

Immutep Limited (ASX: IMM; NASDAQ: IMMP), a notable player in the field of biotechnology focusing on LAG-3 immunotherapies, recently announced encouraging initial safety data from its Phase I clinical trial evaluating IMP761. This first-in-human study, which is both placebo-controlled and double-blind, marks a significant milestone for the company as it explores novel therapies that target cancer and autoimmune diseases.The trial s early results, based on the first three of five single ascending dose cohorts administered to healthy participants, show no treatment-related adverse events. This safety profile is particularly noteworthy as it suggests a low risk of complications arising from the administration o...

IMMP's Stock Performance relative to it's Customers

IMMP's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Immutep Limited	517.83	10.33	-61.43	51
SUBTOTAL	0.00	0.00	0.00	-

Sources: Immutep Limited’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Immutep Limited’s corporate clients.
For your research, we’ve provided 9 tables on Immutep Limited corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.